142 related articles for article (PubMed ID: 23768365)
1. Promising interaction between nanoencapsulated lutein with low molecular weight chitosan: characterization and bioavailability of lutein in vitro and in vivo.
Arunkumar R; Harish Prashanth KV; Baskaran V
Food Chem; 2013 Nov; 141(1):327-37. PubMed ID: 23768365
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-oleic acid-sodium alginate a hybrid nanocarrier as an efficient delivery system for enhancement of lutein stability and bioavailability.
Toragall V; Jayapala N; Vallikannan B
Int J Biol Macromol; 2020 May; 150():578-594. PubMed ID: 32057885
[TBL] [Abstract][Full Text] [Related]
3. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
4. Chitosan/poly-γ-glutamic acid nanoparticles improve the solubility of lutein.
Hong DY; Lee JS; Lee HG
Int J Biol Macromol; 2016 Apr; 85():9-15. PubMed ID: 26712702
[TBL] [Abstract][Full Text] [Related]
5. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-sodium alginate-fatty acid nanocarrier system: Lutein bioavailability, absorption pharmacokinetics in diabetic rat and protection of retinal cells against H
Toragall V; Baskaran V
Carbohydr Polym; 2021 Feb; 254():117409. PubMed ID: 33357895
[TBL] [Abstract][Full Text] [Related]
8. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
9. Wheat germ oil: a potential facilitator to improve lutein bioavailability in mice.
Gorusupudi A; Baskaran V
Nutrition; 2013 May; 29(5):790-5. PubMed ID: 23352176
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan.
Lee E; Lee J; Jon S
Bioconjug Chem; 2010 Oct; 21(10):1720-3. PubMed ID: 20849099
[TBL] [Abstract][Full Text] [Related]
11. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein.
Shanmugam S; Baskaran R; Balakrishnan P; Thapa P; Yong CS; Yoo BK
Eur J Pharm Biopharm; 2011 Oct; 79(2):250-7. PubMed ID: 21550401
[TBL] [Abstract][Full Text] [Related]
12. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
Chadha R; Gupta S; Pathak N
Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
[TBL] [Abstract][Full Text] [Related]
13. Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo.
Dong L; Gao S; Diao H; Chen J; Zhang J
J Biomed Mater Res A; 2008 Mar; 84(3):777-84. PubMed ID: 17635017
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight chitosan in DNA vaccine delivery via mucosa.
Yang X; Yuan X; Cai D; Wang S; Zong L
Int J Pharm; 2009 Jun; 375(1-2):123-32. PubMed ID: 19481698
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.
Jain NK; Jain SK
AAPS PharmSciTech; 2010 Jun; 11(2):686-97. PubMed ID: 20414758
[TBL] [Abstract][Full Text] [Related]
17. Effect of micellar lipids, dietary fiber and β-carotene on lutein bioavailability in aged rats with lutein deficiency.
Mamatha BS; Baskaran V
Nutrition; 2011 Sep; 27(9):960-6. PubMed ID: 21295945
[TBL] [Abstract][Full Text] [Related]
18. Poly (D, L-lactide-co-glycolide)-phospholipid nanocarrier for efficient delivery of macular pigment lutein: absorption pharmacokinetics in mice and antiproliferative effect in Hep G2 cells.
Ranganathan A; Manabe Y; Sugawara T; Hirata T; Shivanna N; Baskaran V
Drug Deliv Transl Res; 2019 Feb; 9(1):178-191. PubMed ID: 30284121
[TBL] [Abstract][Full Text] [Related]
19. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of chitosan nanoparticles with phosphatidylcholine for improved sustain release, basolateral secretion, and transport of lutein in Caco-2 cells.
Shwetha HJ; Shilpa S; Mukherjee MB; Ambedkar R; Raichur AM; Lakshminarayana R
Int J Biol Macromol; 2020 Nov; 163():2224-2235. PubMed ID: 32918957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
